The expression of miR-137 in patients without lymph node metastasis was elevated versus patients with lymph node metastasis (p < 0.05), while its correlation with the expression of GREM1 was inverse. Here, GREM1 is linked to metastatic malignant neoplasm in the lymph nodes.